Sign Up to like & get
recommendations!
2
Published in 2023 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2023.0123
Abstract: This Viewpoint reports on the results of the Clarity AD trial, a phase 3 randomized clinical trial of lecanemab for patients with early Alzheimer disease, in which lecanemab’s clinical efficacy was demonstrated using well-established outcome…
read more here.
Keywords:
forward fight;
fight dementia;
step forward;
dementia yet ... See more keywords